Reneuron Group (RENE)


Latest News

ReNeuron Group Plc to present at the Shares Investor Evening in London on 27th October 2016

Michael Hunt, CFO of ReNeuron Group (RENE) (LSE:RENE) will be giving a briefing at the Shares Investor Evening on...

Notification of Major Interest in Shares

RNS Number: 7883L ReNeuron Group plc 05 October 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ReNeuron Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisi...

Block Listing Review and Total Voting Rights

RNS Number: 5877K ReNeuron Group plc 22 September 2016 22 September 2016 AIM: RENE ReNeuron Group plc ("ReNeuron" or "the Company") Block Listing Review and Total Voting Rights ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, provides the following update in accordance with Schedule Six...

ReNeuron passes AGM resolutions

ReNeuron said that all resolutions put to shareholders at today's Annual General Meeting were duly passed. At 12:12pm: (LO...

All News

14-10-16ReNeuron Group Plc to present at the Shares Investor Evening in London on 27th October 2016StockMarketWire
05-10-16Notification of Major Interest in SharesRNS
22-09-16Block Listing Review and Total Voting RightsRNS
06-09-16ReNeuron passes AGM resolutionsStockMarketWire
06-09-16Result of AGMRNS
06-09-16AGM Trading UpdateRNS
05-08-16Posting of Annual Report and Notice of AGMRNS
04-08-16Stroke clinical data published in The LancetRNS
22-07-16Publication of positive pre-clinical retinal dataRNS
20-07-16Directors' Interest in Shares and Share OptionsRNS
07-07-16Preliminary ResultsRNS
14-06-16Notification of Preliminary ResultsRNS
13-06-16Reuron says patient recruitment completed in stroke trial StockMarketWire
13-06-16Patient recruitment completed in stroke trialRNS
09-06-16ReNeuron pursues brain cancer with exosome platform StockMarketWire
09-06-16Pursues brain cancer with exosome platformRNS
08-06-16ReNeuron Group gives Retinitis pigmentosa update StockMarketWire
08-06-16Retinitis pigmentosa update & Notice of KOL eventRNS
31-05-16Change of AdviserRNS
21-03-16Are Today’s Double-Digit Rises Just The Start For Filtronic Plc, Angle plc And ReNeuron Group Plc?Motley Fool
15-03-16RENE says first patient treated in RP clinical trial StockMarketWire
15-03-16First Patient Treated in RP Clinical TrialRNS
23-02-16ReNeuron Relocates to South WalesRNS
17-02-16Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
17-02-16Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
17-02-16Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
17-02-16Director's DealingsRNS
03-02-16Director Share PurchaseRNS
01-02-16ReNeuron granted key US patentStockMarketWire
01-02-16Notice of Grant of Key US PatentRNS
12-01-16Pre-clinical data relating to exosome platformRNS
11-01-16ReNeuron wins major grantStockMarketWire
11-01-16Wins UK grant to advance its exosome platformRNS
17-12-15ReNeuron establishes Scientific Advisory BoardRNS
09-12-15Are Diageo plc, ReNeuron Group Plc & Persimmon plc On The Cusp Of Huge Returns?Motley Fool
07-12-15ReNeuron losses rise StockMarketWire
07-12-15Interim ResultsRNS
04-12-15Non-executive Director appointmentRNS
12-11-15ReNeuron schedules interimsStockMarketWire
12-11-15Notification of Interim ResultsRNS

RSS feeds

  • Editorial news feed for LSE:RENE Editorial
  • Regulatory news feed for LSE:RENE Regulatory